Skip to main content

insulin aspart Sanofi (Trurapi®)

 

Status: Medicine does not meet criteria for AWMSG assessment

Excluded from appraisal by AWMSG as meets exclusion criterion 11. See AWMSG criteria for appraising a medicine for information.

Medicine details

Medicine name insulin aspart Sanofi (Trurapi®)
Formulation 100 units/ml solution for injection (cartridge and pre-filled pen)
Reference number 4858
Indication

Treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above

Company Sanofi
BNF chapter Endocrine system
Submission type N/A
Status Medicine does not meet criteria for AWMSG assessment
Date of issue 17/02/2021
Follow AWTTC: